Medical Engineering Technologies

Medical Engineering Technologies specialises in medical device and packaging testing, including drug delivery devices such as autoinjectors. MET is equipped for performance testing, chemical analyses and sterile barrier verification, and with accreditation to ISO 17025.

Head Office
Medical Engineering Technologies Ltd
Unit 16 Holmestone Road
Dover
Kent
CT17 0UF
United Kingdom

Phone / Contact

T: +44 8454 588 924
E: solutions@met.uk.com

Connect

Medical Engineering Technologies (MET) specialises medical device and packaging testing with expertise across a broad range of medical devices, including drug delivery devices such as prefilled syringes and injection pens. Services include protocol development, laboratory testing and data analysis. The laboratory is equipped for performance testing, chemical analyses and sterile barrier verification, and with accreditation to ISO 17025.

MET was founded in 1997 and is privately owned. Its clients include medical device and pharmaceutical companies in 20 countries across Africa, Asia, Australasia, Europe and the Americas.

Articles by Medical Engineering Technologies

THE INFLUENCE OF UNCERTAINTY ON CHEMICAL CHARACTERISATION

James Silk discusses the importance of accounting for uncertainty when characterising the extractables profile of a medication, with particular reference to the ISO 10993 standard.

BIOCOMPATIBILITY OF MEDICINAL PRODUCT MEDICAL DEVICE COMBINATIONS FOR AIRWAY DELIVERY

Mark Turner discusses biocompatibility testing for inhaled medical products, with particular reference to ISO 18562, and what Medical Engineering Technologies has learned from three years of breathing component biocompatibility testing.

PREFILLED SYRINGES

VERIFICATION OF INJECTABLES IN TRANSPORT AND STORAGE

Mark Turner discusses the regulations and requirements around testing combination products for their stability in storage over their shelf-life and during transport.

WHICH IS THE BETTER TOXICITY TESTING STRATEGY FOR COMBINATION DEVICES?

Mark Turner explores the issue of toxicity testing for combination devices and asks which is the better testing strategy – ISO 10993 or extractables and leachables?

PREFILLED SYRINGES

THE NEED FOR A FULLY INFORMED LABORATORY IN COMBINATION DEVICE VALIDATION SERVICES

Mark Turner runs through the advantages and processes of working with a high-quality preclinical device testing and validation partner when developing a novel combination product.

EXTRACTABLES AND LEACHABLES FOR INJECTION DEVICES

Mark Turner explains the process involved in ensuring that pharmaceutical containers do not inadvertently transmit toxic substances, while maintaining the effectiveness of the active pharmaceutical ingredients (APIs).

DESIGN VALIDATION TESTING – DRUG DELIVERY DEVICES

From a regulatory perspective, Mark Turner provides a summary of the current requirements of parenteral device manufacturers in the area of design validation testing.

Top